Dyphylline

二羟丙茶碱

Report date: 2023/03/21 10:39:50
NME

Base Information

Drug NameDyphylline
Drug Alias NameDiprophylline双羟丙茶碱二羟丙基茶碱NeothyllineLufyllin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsEmphysemaHeart FailurePulmonary Emphysema +[6] 
Global Approved IndicationsEmphysemaHeart FailurePulmonary Emphysema +[6] 
Approved Indications in ChinaPulmonary EmphysemaAsthmaBronchitis
Original Approved Country/TerritoryUnited States
Original Approved Date1951/03/07
Country/TerritoryCanadaUnited StatesMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTeva
China Registration ClassN/A

Develop Information

Active CompaniesEisai LtdThe Central Pharmaceutical Co Ltd
Inactive CompaniesTeva Pharmaceutical Industries Ltd
Active IndicationsHeart FailurePulmonary EmphysemaAsthma +[4] 
Inactive IndicationsEmphysemaBronchitis, Chronic

Other Information

ATC CodeR03DA01
Related LinksWikipediaDrugBankKEGG